跳至主要内容
临床试验/RBR-72dv9n
RBR-72dv9n招募中3 期

The Association of Miltefosine and Pentoxifylline to Treat Mucocutaneous Leishmaniasis: A Clinical Trial in Brazil

Pós Graduação de Ciências da Saúde - Universidade de Brasília0 个研究点开始时间: 2019年7月22日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 80Y(—)

入选标准

  • Inclusion Criteria: Mucosal and/or cutaneous leishmaniasis, not treated or at least 6 months without any treatment to leishmaniasis; ages between 18 and 80 years old; for patients with cutaneous lesions: duration of disease longer then a 1 month and shorter then 4 yeas; 1 to 3 lesions; larger lesions from 10mm to 50mm; fertile female patients should use at least two contraceptive methods (hormonal and barrier); agree to participate in the study and sign the informed consent term.

排除标准

  • Exclusion Criteria: Use of any leishmanicidal drugs six months prior; clinical or laboratorial evidences of electrocardiographic disorders; renal, hepatic, cardiac diseases, uncontrolled diabetes or AIDS; hypersensitivity to meglucamine antimoniate; pregnancy or lactation; Fertile females that do not agree to use contraceptive methods; patients that do not agree to the informed consent term.

研究者

发起方
Pós Graduação de Ciências da Saúde - Universidade de Brasília

相似试验